12:00 AM
 | 
Aug 01, 2011
 |  BC Week In Review  |  Company News  |  Deals

Biocon, Pfizer deal

Biocon disclosed in its 1Q12 earnings that it will start supplying its biosimilar versions of insulin and glargine...

Read the full 70 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >